DK159373B - CLEANING TABLE FOR SELF-EFFECTIVE CLEANING OF DENTAL SOLUTIONS AND PROCEDURES FOR ITS MANUFACTURING - Google Patents
CLEANING TABLE FOR SELF-EFFECTIVE CLEANING OF DENTAL SOLUTIONS AND PROCEDURES FOR ITS MANUFACTURING Download PDFInfo
- Publication number
- DK159373B DK159373B DK416977A DK416977A DK159373B DK 159373 B DK159373 B DK 159373B DK 416977 A DK416977 A DK 416977A DK 416977 A DK416977 A DK 416977A DK 159373 B DK159373 B DK 159373B
- Authority
- DK
- Denmark
- Prior art keywords
- weight
- acid
- sodium
- purification
- cleaning
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A61Q11/02—Preparations for deodorising, bleaching or disinfecting dentures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Description
- i -- i -
DK 159373 BDK 159373 B
Opfindelsen angår en rensetabiet til selvvirkende rensning af tandproteser med 15 - 25 vægt-% natriumhydrogencarbonat, 8-15 vægt-% natriumhexametaphosphat, surt dinatriumpyrophosphat, mere end 15 vægt-% af en kalkbindende organisk syre, 2-6 vægt-% af et ethylendiaminte-5 traacetat, 1-4 vægt-% højmolekulært polyethylenglykol, mindst 1 vægt-% af en polymer overfladeaktiv farvestofbærer, mere end 0,5 vægt-% tensider og 0,5 - 1,5 vægt-% aromamasse, samt et monoperoxisulfat som oxidationsmiddel, samt en fremgangsmåde til fremstilling af en sådan tablet.The invention relates to a purification table for self-acting cleaning of dentures with 15-25% by weight sodium bicarbonate, 8-15% by weight sodium hexametaphosphate, acid disodium pyrophosphate, more than 15% by weight of a lime-binding organic acid, 2-6% by weight of an ethylene diamine -5 tracetate, 1-4 wt% high molecular weight polyethylene glycol, at least 1 wt% of a polymeric surfactant dye carrier, more than 0.5 wt% surfactants and 0.5 - 1.5 wt% aroma mass, and a monoperoxy sulfate as oxidizing agent, and a method of making such a tablet.
10 Fra tysk offentliggørelsesskrift 2 357 720 kendes der allerede en rensetabiet, hvori mindst ét af de to tilstedeværende lag, der danner tabletten, har den ovennævnte sammensætning. pH-værdien af den ca. 1% opløsning udgør for hvert af de to lag 6,5-7,0. Som kompleksmiddel, der danner chelatagtige komplekser med metalionerne, anvendes der i den 15 kendte rensetabiet ethylendiamintetraacetat. Som kalkbindende organisk syre anvendes der i den kendte rensetabiet citronsyre.From German Patent Specification 2,357,720, there is already known a purification table in which at least one of the two layers present forming the tablet has the above composition. The pH of the approx. 1% solution for each of the two layers is 6.5-7.0. As complexing agent which forms chelate-like complexes with the metal ions, ethylene diamine tetraacetate is used in the known purification stage. Citric acid is used as the lime-binding organic acid in the known purification stage.
I rensetabi etten ifølge tysk offentliggørelsesskrift 2 357 720 tjener natriumhydrogencarbonatet som pH-stabili serende, gasdannende bærer. Natriumhexametaphosphatet virker som blødgører, medens citron-20 syren har en reducerende antimikrobiel virkning og desuden opløser den tandsten, der er tilstede på den tandprotese, der skal renses. Ethylen-tetramintiIsætningen virker blødgørende og demineral i serende som følge af chelatdannelsen, hvorved der desuden kan observeres en tandstensopløsende virkning. Det anvendte højmolekulare polyethylenglykol virker 25 som antimikrobielt sprængmiddel. Tensiderne har en emulgerende virkning og nedbryder ved den kendte rensetabiet tandprotesebelægningen på grund af deres overfladeaktivitet. Natriumpyrophosphatet virker reducerende og blødgørende og nedbryder ved overfladeaktiv virkning tandprotesebelægningen. De anvendte monoperoxysulfater, altså salte af monoperoxy-30 svovlsyren, tjener som oxidationsmidler. Som polymer farvestofbærer med overfladeaktiv rensevirkning anvendes der i den kendte rensetabiet fortrinsvis et i handelen almindeligt natriumsalt af en organisk syre med flere carboxyl grupper (polycarbonsyre) som beskrevet i tysk offentliggørelsesskrift 2 357 720, der ligeledes forbedrer rensevirkningen. Det 35 al kylbenzensul fonat, der anvendes som tensid ifølge tysk offentliggø-In the purification tablet according to German publication specification 2,357,720, the sodium bicarbonate serves as a pH-stabilizing, gas-forming carrier. The sodium hexametaphosphate acts as plasticizer, while the citric acid has a reducing antimicrobial effect and further dissolves the tartar present on the denture to be cleansed. The ethylene-tetramine additive acts softening and demineral in serous as a result of chelation, thereby further observing a tartar dissolving effect. The high molecular weight polyethylene glycol used acts as an antimicrobial disintegrant. The surfactants have an emulsifying effect and degrade at the known cleaning stage the denture coating due to their surface activity. The sodium pyrophosphate acts as a reducing and emollient and, by surfactant, degrades the denture coating. The monoperoxy sulfates used, i.e. salts of the monoperoxy sulfuric acid, serve as oxidizing agents. As the polymeric dye carrier with surfactant purification effect, in the known purification stage, a commercially available sodium salt of an organic carb with several carboxylic groups (polycarboxylic acid) is preferably used, as described in German disclosure 2,357,720, which also improves the purification effect. The 35-all benzene sulphonate used as a surfactant according to German publication
DK 159373 BDK 159373 B
- 2 - relsesskrift 2 357 720, er fx. natriumdodecylbenzensul fonat, hvorhos der også kan være tilsat fedtsyre-dinatriumsulfosuccinater. Den foretrukne molekylvægt af det anvendte polyethylenglykol kan for den kendte rensetabiet udgøre mellem ca. 4.000 og 25.000, fortrinsvis ca. 20.000.- 2 - commencement letter 2 357 720, for example. sodium dodecylbenzenesulfonate, to which may also be added fatty acid disodium sulfosuccinates. The preferred molecular weight of the polyethylene glycol used may for the prior art purification constitute between ca. 4,000 and 25,000, preferably approx. 20,000.
5 Alt i alt har rensetabi etten ifølge tysk offentliggørelsesskrift 2 357 720 vist sig at være god. Det har dog til mange anvendelsesformål vist sig at være ønskværdigt at realisere væsentligt kortere rensetider end de 10 - 15 minutter, der kræves ved rensetabi etterne ifølge tysk offentliggørelsesskrift 2 357 720. Den tolagede opbygning af den kendte 10 rensetabiet har ligeledes i mange tilfælde vist sig at være forholdsvis ugunstig i pris.5 All in all, according to German publication specification 2 357 720, the purification tab has proved to be good. However, for many applications, it has been found desirable to realize substantially shorter cleaning times than the 10-15 minutes required by the cleaning tab according to German publication specification 2,357,720. The two-layered structure of the known 10 cleaning table has also been found in many cases. to be comparatively unfavorable in price.
Det er kendt, at aflejringer af calciumforbindelser på proteser henholdsvis på disses metaldele og på metaldele i tandreguleringsapparater bedre opløses af særligt sure rensemidler som fx. beskrevet i CH-15 patentskrift 480 840, hvorved der foreligger pH-værdier fra 1,5 - 5, men dette har den ulempe, at de anvendte, chelatdannende kompleksmidler ikke mere kan blive virksomme, fordi den nedre pH-værdigrænse for en sådan virkning af kompleksdannerne ligger ved ca. pH 6.It is known that deposits of calcium compounds on dentures respectively on their metal parts and on metal parts in dental controllers are better dissolved by particularly acidic cleaners such as e.g. disclosed in CH-15 patent 480 840, whereby pH values of 1.5-5 are present, but this has the disadvantage that the chelating complexing agents used can no longer become effective because the lower pH value for such an effect of the complexes are located at approx. pH 6.
Opfindelsen har derfor til opgave at tilvejebringe en rensetabiet, 20 der kun består af ét lag, og som yder en meget hurtig, pålidelig rensning.It is therefore the object of the invention to provide a purification set, consisting of only one layer, which provides a very fast, reliable purification.
Ifølge opfindelsen løses denne opgave ved, at den kalkbindende organiske syre ved en rensetabiet af den indledningsvis angivne art til opnåelse af en samlet rensetid på 3 - 5 minutter og en opløsningstid på 25 1 - 2 minutter, er amidosulfonsyre, at ethylendiamintetraacetatet dannes af den frie syre (H4EDTA), at der anvendes 1,5 - 2,5 vægt-% dial -kylthiokarbamid, 0,2 - 0,5 vægt-% af en ikke-ionogen, fluorholdig tensid valgt blandt forbindelserne med den almene formel: 30 C8F150 (CH2CH20)n CgF15, hvor n har en gennemsnitsværdi på 23, eller c8f15° (^2^2^^n CH3* hvor n har en gennemsnitsværdi på 8, og hvor c8f15 er tetrameren af tetrafluorethen, hvorhos en 1% opløsning af tab-35 letten i vand giver en pH-værdi på 6,3 - 6,5.According to the invention, this task is solved by the lime-binding organic acid at a purification stage of the type initially specified to obtain a total purification time of 3 - 5 minutes and a dissolution time of 25 1-2 minutes, amidosulfonic acid is formed by the free ethylene diamine tetraacetate. acid (H4EDTA) using 1.5 - 2.5% by weight of dialkylthiourea, 0.2 - 0.5% by weight of a nonionic, fluorine-containing surfactant selected from the compounds of the general formula: C8F150 (CH2CH2O) n CgF15, where n has an average value of 23, or c8f15 ° (^ 2 ^ 2 ^^ n CH3 * where n has an average value of 8 and where c8f15 is the tetramer of tetrafluoroethene, wherein a 1% solution of loss The -35 light in water gives a pH of 6.3 - 6.5.
DK 159373 BDK 159373 B
- 3 -- 3 -
En særlig foretrukken udføre!sesform ifølge opfindelsen er, at den polymere farvestofbærer består af 1 - 2 vægt-% af et i handelen almindeligt natriumsalt af en organisk syre med flere carboxyl grupper (poly-carbonsyre), fortrinsvis natriumpolyacrylat. Især kan der også tilsæt-5 tes 1 - 2 vægt-% af et krydsforgrenet polyvinyl pyrrol i don.A particularly preferred embodiment of the invention is that the polymeric dye carrier consists of 1 to 2% by weight of a commercially common sodium salt of an organic acid having several carboxyl groups (polycarboxylic acid), preferably sodium polyacrylate. In particular, 1-2% by weight of a cross-branched polyvinyl pyrrole in don may also be added.
Særlig god har den følgende sammensætning for en rensetabiet ifølge opfindelsen vist sig at være: 10 - 12 vægt-% natriumhexametaphosphat, 10 18 - 20 vægt-% natriumhydrogencarbonat, 1.5 - 2,0 vægt-% polyethylenglykol med en molekylvægt på 20.000, 24 - 30 vægt-% amidosul fonsyre, 20 - 24 vægt-% monoperoxysulfat, 15 5,5 - 7,5 vægt-% surt di natriumpyrophosphat, 2-3 vægt-% ethylendiamintetraeddikesyre, 1 - 2,0 vægt-% natriumpolyacrylat med farvestoftil sætning, 0,5 - 1,5 vægt-% pebermyntepulver, 0,5 - 1,5 vægt-% natriumdodecylbenzensul fonat, 20 0,3 - 1,0 vægt-% laurylpolyglykolethersulfosuccinat, 0,2 - 0,4 vægt-% af en ikke-ionogen, fluorholdig tensid valgt i gruppen bestående af: C8F15° (CH2CH2°)n C8F15» *lvor n har en 9ennem~ snitsværdi på 23, eller 25 c8f15° (CH2CH2°Jn CH3* hvor n har en 9ennem_ snitsværdi på 8, og hvor CgFjg er tetrameren af tetrafluorethen, 0,8 - 1,1 vægt-% natriumbenzoat, 1.5 - 2,0 vægt-% dial kylthiokarbamid, 30 1,5 - 2,0 vægt-% polyvinylpolypyrrolidon, 0,5 - 1,5 vægt-% dinatriumsulfosuccinat, og 0,8 - 1,2 vægt-% al kylarylsul fonat.Particularly good, the following composition for a purification tablet according to the invention has been found to be: 10-12% by weight sodium hexametaphosphate, 10-18-20% by weight sodium bicarbonate, 1.5-2.0% by weight polyethylene glycol having a molecular weight of 20,000, 24% by weight. 30 wt% amidosul phonic acid, 20-24 wt% monoperoxy sulfate, 5.5 - 7.5 wt% acid di sodium pyrophosphate, 2-3 wt% ethylenediaminetetraacetic acid, 1 - 2.0 wt% sodium polyacrylate with dye addition 0.5 - 1.5% by weight peppermint powder, 0.5-1.5% by weight sodium dodecylbenzenesulphonate, 0.3 - 1.0% by weight lauryl polyglycol ether sulfosuccinate, 0.2 - 0.4% by weight of a nonionic, fluorine-containing surfactant selected from the group consisting of: C8F15 ° (CH2CH2 °) n C8F15 »* where n has a 9 average cut value of 23, or 25 c8f15 ° (CH2CH2 ° Jn CH3 * where n has a cut average value of 8, and wherein CgFjg is the tetramer of tetrafluoroethene, 0.8-1.1% by weight sodium benzoate, 1.5-2.0% by weight dialkylthiourea, 1.5-2.0% by weight pol yvinyl polypyrrolidone, 0.5-1.5% by weight disodium sulfosuccinate, and 0.8-1.2% by weight all chylarylsulphonate.
Fremgangsmåden ifølge opfindelsen til fremstilling af en renseta-35 blet består i, at de ovennævnte mængder natriumhydrogencarbonat, natri-The process of the invention for the preparation of a purifying tablet consists in the above-mentioned amounts of sodium hydrogen carbonate,
DK 159373 BDK 159373 B
- 4 - umhexametaphosphat, polyethylenglykol og 30 - 50 vægt-% af den samlede mængde amidosulfonsyre først blandes med hinanden og forarbejdes til et granulat, at det således fremstillede granulat dernæst blandes med de øvrige komponenter, og at rensetabi etten fremstilles af blandingen.- 4 - umhexametaphosphate, polyethylene glycol and 30 - 50% by weight of the total amount of amidosulfonic acid are first mixed with each other and processed into a granulate, the granulate thus produced is then mixed with the other components and the purified acetate is produced from the mixture.
5 Særligt foretrukne udførelsesformer ifølge denne fremgangsmåde be skrives i de tilsvarende underkrav.Particularly preferred embodiments of this method are described in the corresponding subclaims.
I modsætning til de hidtil almindelige rensetabi etter til tandproteser, der er stærkt alkaliske, neutrale og svagt sure (fx. renseta-bletten ifølge tysk offentliggørelsesskrift 2 357 720), anvendes der 10 ved rensetabletten ifølge opfindelsen et pH-område, der kan indstilles nøjagtigt mellem 6,3 og 6,5, med en variationsbredde på højst ± 0,3. Rensetabletten ifølge opfindelsen gør det ikke mere ubetinget påkrævet at rense tandprotesen dagligt for at fjerne de aflejringer, der opstår i løbet af dagen, og som består af føderester og spytaflejringer, men 15 yder med en overordentlig hurtig, hidtil ikke opnået opløsningstid på ca. 1 - 2 minutter en fuld rensevirkning i en samlet rensetid på 3 - 5 minutter. Det er vigtigt for rensetabletten ifølge opfindelsen, at ami-dosulfonsyren anvendes sammen med dialkylthiourinstoffet, der virker som antikorrosivmiddel. Et sådant dialkylthiourinstof, der altså tjener 20 som inhibitor for amidosulfonsyren for at undgå eventuelle beskadigelser af protesematerialet eller metaldelene, fås under handelsnavnet LITHSOLVENT-HC® hos firmaet Keller & Bohacek KG, Diisseldorf. Dette antikorrosivmiddel henholdsvis denne inhibitor virker synergistisk sammen med det natriumbenzoat, der anvendes til tabletten ifølge opfindelsen, 25 og hvis desinficerende virkning er kendt, hvorved der opstår en yderligere synergistisk virkning med det aktive oxygen (fra monoperoxysulfat-et), da inhibitoren virker som antioxidant. En synergistisk virkning optræder også mellem antikorrosivmidlet og amidosulfonsyren. Herved forhindres, at peroxiderne nedbrydes ved lagring af rensetabletten.In contrast to the previously common purification tablets for dentures which are highly alkaline, neutral and weakly acidic (e.g., the purification tablet according to German publication specification 2,357,720), a pH range which can be precisely adjusted can be used in the purification tablet according to the invention. between 6.3 and 6.5, with a variation width of ± 0.3. The cleaning tablet according to the invention no longer requires the daily cleaning of the denture to remove the deposits that occur during the day, which consist of fever residue and saliva deposits, but provide an extremely fast, unresolved time of approx. 1 - 2 minutes a full cleaning effect for a total cleaning time of 3 - 5 minutes. It is important for the purification tablet of the invention that the amidosulfonic acid be used with the dialkyl thiourea which acts as an anticorrosive agent. Such a dialkyl thiourea, which thus serves as an inhibitor of the amidosulfonic acid to avoid any damage to the prosthetic material or metal parts, is available under the trade name LITHSOLVENT-HC® from Keller & Bohacek KG, Diisseldorf. This anticorrosive agent or inhibitor, respectively, acts synergistically with the sodium benzoate used for the tablet of the invention, the disinfectant of which is known, thereby producing a further synergistic action with the active oxygen (from the monoperoxysulfate) as the inhibitor acts as an antioxidant. . A synergistic effect also occurs between the anticorrosive agent and the amidosulfonic acid. This prevents the peroxides from being degraded by storing the cleaning tablet.
30 Særligt velegnet som natriumhexametaphosphat er et instantiseret natri-umhexametaphosphat, der fås under navnet Budit 8 H®.Particularly suitable as sodium hexametaphosphate is an instantiated sodium hexametaphosphate available under the name Budit 8 H®.
Ved til rensetabletten ifølge opfindelsen at anvende pulverformet ethylendiamintetraeddikesyre, hvis pH-værdi er 2,5 - 3 i en mættet vandig opløsning, kræves der en væsentlig mindre mængde chelatdannende 35 kompleksdannere, end det ville være tilfældet, hvis der ved den kendte - 5 -By using the purifying tablet of the invention powdered ethylenediaminetetraacetic acid, whose pH is 2.5-3 in a saturated aqueous solution, requires a substantially smaller amount of chelating complexers than would be the case with the known - 5 -
DK 159373 BDK 159373 B
tablet blev anvendt ethylendiamintetraacetat. En pulverformet ethylen-diamintetraeddikesyre (H4EDTA), der anvendes til tabletten ifølge opfindelsen, fås under handelsnavnet Versene® Acid hos det amerikanske firma Dow Chemical Company.tablet was used ethylene diamine tetraacetate. A powdered ethylene-diamine tetraacetic acid (H4EDTA) used for the tablet of the invention is available under the trade name Versene® Acid of the US company Dow Chemical Company.
5 Ydermere har kombinationen af de tensider, der anvendes til rense- tabletten ifølge opfindelsen, med den ikke-ionogene fluorkemiske substans den virkning, at der opnås overordentlig lave overfladespændinger af rensevæsken på 25-10"7 - 26·10"7 N/m. Ved disse lave overfladespændinger stiger rensevæskens befugtningsevne henholdsvis emulgeringsevne, 10 hvilket resulterer i den korte rensetid. Fortrinsvis kan der som tensider fx. anvendes de råstoffer, der er kendt under handelsnavnet Steina-pol®NKS 100 og Rewo-DERM®S 1333 fra firmaet Rewo Chemische Fabrik GmbH,Furthermore, the combination of the surfactants used for the cleaning tablet according to the invention with the nonionic fluorochemical substance has the effect that extremely low surface tension of the cleaning fluid of 25-10 "7 - 26 · 10" 7 N / m is obtained. . At these low surface stresses, the wetting ability of the cleaning liquid increases, respectively, the emulsifying ability, which results in the short cleaning time. Preferably, as surfactants e.g. the raw materials known under the trade name Steina-pol®NKS 100 and Rewo-DERM®S 1333 are used by the company Rewo Chemische Fabrik GmbH,
Steinau. Disse tensider giver et varigt, fedt og stift skum, hvorved overfladespændingen i en 0,1% vandig opløsning for NKS 100 ligger ved 15 ca. 25· 10-7 N/m og for S 1333 ved 30 - 35·10“7 N/m. Ved tilsætning af den ikke-ionogene fluorkemiske substans, der anvendes til rensetabi etten ifølge opfindelsen, og som fås under betegnelsen Monflor®51 eller Monflor®52 hos firmaet ICI, i en koncentration på ca. 0,2 - 0,5% i tabletsammensætningen, aftager overfladespændingen af rensevæsken til 20 25·10"7 N/m - 26·10"7 N/m. Herved forstærkes befugtningsevnen og indtrængningsevnen af tensiderne særligt.Steinau. These surfactants provide a durable, greasy and rigid foam, whereby the surface tension in a 0.1% aqueous solution for NKS 100 is at about 15%. 25 · 10-7 N / m and for S 1333 at 30 - 35 · 10 “7 N / m. By adding the nonionic fluorochemical substance used for the purification tablet of the invention, obtained under the designation Monflor®51 or Monflor®52 by the company ICI, at a concentration of approx. 0.2 - 0.5% in the tablet composition, the surface tension of the cleaning liquid decreases to 20 25 · 10 "7 N / m - 26 · 10" 7 N / m. In this way the wetting and penetration of the surfactants are particularly enhanced.
Med rensetabletten ifølge opfindelsen er det for første gang muligt at tilvejebringe et yderst hurtigt arbejdende rensemiddel, der er virksomt i en rensevæske med en overfladespænding på kun 25*10“7 -25 26·10-7 N/m, medens den gennemsnitlige spænding ligger ved 35·10~7 -90·10“7 N/m for andre rensemidler.With the cleaning tablet according to the invention, it is possible for the first time to provide an extremely fast cleaning agent which is effective in a cleaning liquid with a surface tension of only 25 * 10 "7 -25 26 · 10-7 N / m, while the average voltage is at 35 · 10 ~ 7 -90 · 10 “7 N / m for other detergents.
Som presse- og hjælpemidler kan der anvendes lignende stoffer, som også anvendes i rensetabletten ifølge tysk offentliggørelsesskrift 23 57 720. Herunder kan det dreje sig om sukkerfedtsyreestre, der fås un-30 der handelsnavnet Wasag®7 og Wasag®15. Disse produkter fås i Schweiz, Østrig og i østbloklandene under handelsnavnet Sucrapan . Som presse-og glittemidler kan der ogs(å anvendes substanser, som fås under handelsnavnet Luviskol®V 64, Aerosil®, Tamol®, Awycel® eller Waxy®Mais, alt i alt velegnede naturlige stivelser, forsukrede stivelser og deri-35 vater såsom stivelsessukker, dextrose vandfri, polyethylenglykol og - 6 -As press and auxiliary agents, similar substances can be used, which are also used in the purification tablet according to German publication specification 23 57 720. These may include sugar fatty acid esters available under the trade names Wasag®7 and Wasag®15. These products are available in Switzerland, Austria and the Eastern Bloc countries under the trade name Sucrapan. As press and lubricants, substances (available under the trade name Luviskol®V 64, Aerosil®, Tamol®, Awycel® or Waxy®Mais) may also be used, all in all suitable natural starches, sugared starches and derivatives such as starch sugar, dextrose anhydrous, polyethylene glycol and - 6 -
DK 159373 BDK 159373 B
mikrokristallinske celluloser.microcrystalline celluloses.
I det følgende forklares rensetabi etten og fremgangsmåden ifølge opfindelsen ved hjælp af et udførelseseksempel.In the following, the purification table and method of the invention are explained by an exemplary embodiment.
55
Eksempel;Example;
Til fremstilling af en rensetabiet ifølge opfindelsen indfyldes der først 10,55 vægtdele komplekserings- og dispergeringsmiddel, som 10 kan være med phosphat eller være phosphatfri, der fås under handelsnav-net Budit®8 H, 10,85 vægtdele amidosulfonsyre (sulfamidsyre), 19,00 vægtdele natriumhydrogencarbonat og 1,81 vægtdele polyethylenglykol med en molekylvægt på 20.000 via en traditionel doseringsenhed og et hejseværk i en blandekedel. Blandekedelen kobles derefter til en GLATT®-15 granulator. Komponenterne, der skal granuleres, opvarmes af varm luft på 100 - 115°C, hvorved lufttilførselsåbningen indstilles på trin 5 til 6 og afgangsluftåbningen på trin 2 til 3. Under stadig omhvirvl ing opvarmes de komponenter, der skal granuleres, og ved 60 - 65°C - og denne temperatur skal holdes i ca. 10 minutter - foregår granulationen 20 så. Ved denne temperatur på 60 - 65°C smelter polyethylenglykol en 20.000 totalt i det nævnte tidsrum på ca. 10 minutter, hvorved granulationen gennemføres fuldstændigt. Ved den samme indstilling af tilfør-selsluft- og afgangsluftåbningen afkøles granulatet under tilførsel af køleluft med en temperatur på 6 - 10°C til ca. 25°C. Dernæst fyldes 25 granulatet i luft- og fugtighedstætte beholdere, fx. i polyethylenpo- ser, hvorved der med regelmæssige prøver kontrolleres, at fugtigheden maksimalt udgør 0,25% H20.To prepare a purification tablet according to the invention, 10.55 parts by weight of complexing and dispersing agent, which may be 10 with phosphate or phosphate-free, obtained under the trade name Budit® 8 H, 10.85 parts by weight of amidosulfonic acid (sulfamic acid), are first filled. , 00 parts by weight of sodium hydrogen carbonate and 1.81 parts by weight of polyethylene glycol with a molecular weight of 20,000 via a conventional dosing unit and a hoist in a mixing boiler. The mixing boiler is then coupled to a GLATT®-15 granulator. The components to be granulated are heated by hot air at 100 - 115 ° C, setting the air supply opening at steps 5 to 6 and the exhaust air opening at steps 2 to 3. During still stirring, the components to be granulated are heated and at 60 - 65 ° C - and this temperature should be kept for approx. 10 minutes - granulation takes place 20 then. At this temperature of 60-65 ° C, polyethylene glycol melts a total of 20,000 in the said period of approx. 10 minutes, complete granulation. At the same setting of the supply air and exhaust air apertures, the granulate is cooled under cooling air supply with a temperature of 6 - 10 ° C to approx. 25 ° C. Next, the granules are filled into air- and moisture-tight containers, e.g. in polyethylene bags, with regular tests to check that the maximum moisture content is 0.25% H2 O.
42,21 vægtdele af det således fremstillede granulat blandes som beskrevet i tysk offentliggørelsesskrift 2 357 720 med de øvrige kom-30 ponenter af rensetabi etten, nemlig i dette udførelseseksempel med 22,60 vægtdele monoperoxysulfat, 6,23 vægtdele di natriumpyrophosphat, 2,26 vægtdele ethylendiamintetraeddikesyre (Versene Acid), 1,18 vægtdele af et i handelen almindeligt natriumsalt af en tidligere anført polycar-bonsyre med farvestofti Isætning, 1,00 vægtdele pebermyntepulver, 0,81 35 vægtdele natriumdodecylbenzensul fonat (Steinaryl®NKS 100 fra firmaet - 7 -42.21 parts by weight of the granulate thus prepared are mixed as described in German publication specification 2,357,720 with the other components of the purification tablet, namely in this embodiment with 22.60 parts by weight of monoperoxy sulfate, 6.23 parts by weight of sodium pyrophosphate, 2.26 parts by weight of ethylene diamine tetraacetic acid (Versene Acid), 1.18 parts by weight of a commercially available sodium salt of a previously stated polycarboxylic acid with dye. -
DK 159373 BDK 159373 B
Rewo Chemische Werke GmbH), 0,54 vægtdele laurylpolyglykolethersulfo-succinat (Rewo-DERM®S 1333 fra firmaet Rewo Chemische Fabrik GmbH), 0,30 vægtdele af en ikkeionogen, fluorkemisk substans (Monflor®51 fra firmaet ICI), 0,90 vægtdele natriumbenzoat, 1,81 vægtdele dial kylthiou-5 rinstof (LICHTSOLVENT-HC® fra firmaet Keller & Bohacek KG, Dusseldorf), 1,81 vægtdele polyvinylpolypyrrolidon (Plasdone®XL fra firmaet GAF (Deutschland) GmbH), 1,00 vægtdele di natriumsulfosuccinat (handelsnavn Wasag®7), 1,00 vægtdele al kylarylsul fonat (Wasag®15) og yderligere 16,27 vægtdele amidosulfonsyre (sulfamidsyre). Efter blandingen, tør-10 ringen og sigtningen blev der presset til en rensetabiet. En 17« vandig opløsning har en pH-værdi på 6,3 - 6,5.Rewo Chemische Werke GmbH), 0.54 parts by weight of lauryl polyglycol ether sulfosuccinate (Rewo-DERM®S 1333 from the company Rewo Chemische Fabrik GmbH), 0.30 parts by weight of a nonionic, fluorochemical substance (Monflor®51 from the company ICI), 0.90 parts by weight of sodium benzoate, 1.81 parts by weight of dialkyl thiourea (LICHTSOLVENT-HC® from Keller & Bohacek KG, Dusseldorf), 1.81 parts by weight of polyvinyl polypyrrolidone (Plasdone®XL from GAF (Deutschland) GmbH), 1.00 parts by weight sodium sulfosuccinate (trade name Wasag®7), 1.00 parts by weight of all chylaryl sulfonate (Wasag®15) and an additional 16.27 parts by weight of amidosulfonic acid (sulfamic acid). After mixing, drying and sieving, a purification table was pressed. A 17 'aqueous solution has a pH of 6.3 - 6.5.
Opfindelsens kendetegn, der er blevet klarlagt både i den ovenstående beskrivelse og i de efterfølgende krav, kan både enkeltvis og i vilkårlige kombinationer være væsentlige for realisationen af opfindel-15 sen i dens forskellige udførelsesformer.The features of the invention, which have been elucidated both in the foregoing description and in the following claims, can be both individually and in any combination to be essential for the realization of the invention in its various embodiments.
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2658450A DE2658450C3 (en) | 1976-12-23 | 1976-12-23 | Cleaning tablet for automatic cleaning of dentures in an aqueous solution as well as processes for their manufacture |
DE2658450 | 1976-12-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK159373B true DK159373B (en) | 1990-10-08 |
DK159373C DK159373C (en) | 1991-03-11 |
Family
ID=5996414
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK416977A DK159373C (en) | 1976-12-23 | 1977-09-21 | CLEANING TABLE FOR SELF-EFFECTIVE CLEANING OF DENTAL SOLUTIONS AND PROCEDURES FOR ITS MANUFACTURING |
DK476977A DK416977A (en) | 1976-12-23 | 1977-09-21 | CLEANING TABLE FOR AUTOMATIC CLEANING OF DENTAL PROSTITUTES IN WATER SOLUTION AND METHOD OF ITS MANUFACTURE |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK476977A DK416977A (en) | 1976-12-23 | 1977-09-21 | CLEANING TABLE FOR AUTOMATIC CLEANING OF DENTAL PROSTITUTES IN WATER SOLUTION AND METHOD OF ITS MANUFACTURE |
Country Status (21)
Country | Link |
---|---|
AT (1) | AT361125B (en) |
AU (1) | AU518376B2 (en) |
BE (1) | BE861767A (en) |
CA (1) | CA1105387A (en) |
CH (1) | CH633710A5 (en) |
DD (1) | DD134484A5 (en) |
DE (1) | DE2658450C3 (en) |
DK (2) | DK159373C (en) |
ES (1) | ES465220A1 (en) |
FR (1) | FR2374899A1 (en) |
GB (1) | GB1579401A (en) |
HK (1) | HK55781A (en) |
HU (1) | HU176692B (en) |
IT (1) | IT1087496B (en) |
LU (1) | LU78519A1 (en) |
NL (1) | NL175137C (en) |
NO (1) | NO145779C (en) |
SE (1) | SE433303B (en) |
SG (1) | SG882G (en) |
YU (1) | YU281677A (en) |
ZA (1) | ZA776880B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA792043B (en) * | 1978-05-08 | 1980-05-28 | Scherico Ltd | Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them |
DK435881A (en) * | 1981-10-01 | 1983-04-02 | Niels Ole Vesterager | WASHING ACTIVE DOSAGE UNIT, METHOD OF PREPARING IT AND THE USE OF IT |
MY106919A (en) * | 1990-08-31 | 1995-08-30 | Kao Corp | Composition for use in oral cavity. |
GB9723531D0 (en) * | 1997-11-05 | 1998-01-07 | Procter & Gamble | Cleansing tablets |
US6077501A (en) * | 1998-06-30 | 2000-06-20 | Block Drug Company, Inc. | Denture cleanser |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1186342A (en) * | 1966-12-22 | 1970-04-02 | Unilever Ltd | Cleansing Compositions |
DE2357720C3 (en) * | 1973-11-19 | 1983-01-13 | Kukident Richardson GmbH & Co. KG, 6940 Weinheim | Cleaning tablets for dentures or the like and processes for their manufacture |
-
1976
- 1976-12-23 DE DE2658450A patent/DE2658450C3/en not_active Expired
-
1977
- 1977-09-13 NO NO773149A patent/NO145779C/en unknown
- 1977-09-14 SE SE7710284A patent/SE433303B/en not_active IP Right Cessation
- 1977-09-21 DK DK416977A patent/DK159373C/en not_active IP Right Cessation
- 1977-09-21 DK DK476977A patent/DK416977A/en unknown
- 1977-09-23 NL NLAANVRAGE7710421,A patent/NL175137C/en not_active IP Right Cessation
- 1977-11-04 AT AT789977A patent/AT361125B/en not_active IP Right Cessation
- 1977-11-09 IT IT29485/77A patent/IT1087496B/en active
- 1977-11-14 GB GB47377/77A patent/GB1579401A/en not_active Expired
- 1977-11-15 LU LU78519A patent/LU78519A1/xx unknown
- 1977-11-17 ZA ZA00776880A patent/ZA776880B/en unknown
- 1977-11-18 AU AU30793/77A patent/AU518376B2/en not_active Expired
- 1977-11-25 YU YU02816/77A patent/YU281677A/en unknown
- 1977-12-06 CH CH1491177A patent/CH633710A5/en not_active IP Right Cessation
- 1977-12-12 BE BE183380A patent/BE861767A/en not_active IP Right Cessation
- 1977-12-15 FR FR7737914A patent/FR2374899A1/en active Granted
- 1977-12-19 ES ES77465220A patent/ES465220A1/en not_active Expired
- 1977-12-21 DD DD77202845A patent/DD134484A5/en not_active IP Right Cessation
- 1977-12-22 HU HU77KU528A patent/HU176692B/en unknown
- 1977-12-22 CA CA293,728A patent/CA1105387A/en not_active Expired
-
1981
- 1981-11-12 HK HK557/81A patent/HK55781A/en unknown
-
1982
- 1982-01-11 SG SG8/82A patent/SG882G/en unknown
Also Published As
Publication number | Publication date |
---|---|
HU176692B (en) | 1981-04-28 |
GB1579401A (en) | 1980-11-19 |
CA1105387A (en) | 1981-07-21 |
LU78519A1 (en) | 1978-03-20 |
SG882G (en) | 1983-07-08 |
YU281677A (en) | 1984-04-30 |
NO145779B (en) | 1982-02-22 |
AT361125B (en) | 1981-02-25 |
DE2658450A1 (en) | 1978-06-29 |
NO773149L (en) | 1978-06-26 |
IT1087496B (en) | 1985-06-04 |
CH633710A5 (en) | 1982-12-31 |
DE2658450B2 (en) | 1978-10-26 |
FR2374899B1 (en) | 1981-12-31 |
DK159373C (en) | 1991-03-11 |
ES465220A1 (en) | 1979-01-01 |
AU518376B2 (en) | 1981-10-01 |
HK55781A (en) | 1981-11-20 |
DE2658450C3 (en) | 1979-06-21 |
ATA789977A (en) | 1980-07-15 |
NL175137B (en) | 1984-05-01 |
SE433303B (en) | 1984-05-21 |
DK416977A (en) | 1978-06-24 |
BE861767A (en) | 1978-06-12 |
ZA776880B (en) | 1978-09-27 |
NL175137C (en) | 1984-10-01 |
FR2374899A1 (en) | 1978-07-21 |
SE7710284L (en) | 1978-06-24 |
NO145779C (en) | 1982-06-02 |
NL7710421A (en) | 1978-06-27 |
AU3079377A (en) | 1979-05-24 |
DD134484A5 (en) | 1979-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4155868A (en) | Enzyme and active oxygen containing denture cleanser tablet | |
US4256599A (en) | Denture cleansing tablet and process for making | |
US3355392A (en) | Alkaline germicidal cleaner with color indicator | |
EP0842257B1 (en) | Dish washer product in tablet form | |
KR100342089B1 (en) | Composition for cleaning and wetting contact lenses | |
EP0506788B1 (en) | A herbicidal formulation containing glyphosate acid | |
CA1240619A (en) | Method for deodorizing hypochlorite denture cleansing solutions and product | |
US3821117A (en) | Effervescent tablet | |
US4217234A (en) | Denture cleansing tablet and method of manufacturing the same | |
DK157729B (en) | Denture CLEANER | |
EP1242573A2 (en) | Composition for use in a dishwasher | |
FI116449B (en) | Noise granules and process for its preparation | |
DK159373B (en) | CLEANING TABLE FOR SELF-EFFECTIVE CLEANING OF DENTAL SOLUTIONS AND PROCEDURES FOR ITS MANUFACTURING | |
JPH10330235A (en) | Agent for washing artificial tooth | |
EP3033411B1 (en) | Multiphase cleaning tablet | |
US20070298991A1 (en) | Denture cleanser composition | |
CA1112814A (en) | Built liquid bleaching compositions | |
EP0010412B1 (en) | Denture cleansing composition and process for its preparation | |
WO2011040201A1 (en) | Denture detergent | |
JPH0597640A (en) | Dentrue detergent | |
DE19934704A1 (en) | Washing or detergent agent molded article comprises particles of average size below 800 microns containing a non-surfactant solid dispersant not from mono-, di-, tri-, oligo- and poly-saccharides or paraffin | |
KR20070022437A (en) | Laundry detergent composition and method for preparing thereof | |
US4810294A (en) | Solubilizer for water-insoluble alginates, aqueous solution thereof and dissolving method using the aqueous solution | |
JPS63261000A (en) | Liquid detergent composition for automatic tableware washing machine | |
JP3990522B2 (en) | Oral preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |